SLE is a complex, self-immunised disease with a plethora of systems and organs, the treatment of which requires a multifaceted and integrated consideration.
I. Drug treatment
1. Sugar cortex hormones
– It’s the basic drug for SLE. It has a strong anti-inflammation and immune inhibition effect. For light SLE patients, such as skin mucous membranes, small doses of sugar cortex hormones, such as Penneson, may be used. During the period of disease activity, especially when it is heavy and important organs such as kidneys and blood systems, a larger dose of sugar cortex hormone may be used, or even a dose of impact. However, long-term use of sugar cortex hormones has many adverse effects, such as osteoporosis, increased blood sugar and increased risk of infection. Thus, in the course of their use, the doctor gradually reduces the amount depending on the extenuating circumstances.
2. Immunosuppressants
– cyclophosphorus: a very important drug for serious SLE performances such as lupus kidneyitis. It can inhibit excessive activity of the immune system and reduce the generation of its own antibodies. But it also has some side effects, such as bone marrow inhibition, sex gland inhibition, etc.
– Numeric phenol: A new type of immunosuppressant with a high degree of selective inhibition on lymphocytes. During the maintenance phase, it may have a better tolerance than cyclophosphate, especially for patients who cannot withstand the side effects of cyclophosphate.
– Sulphurium: It is also one of the commonly used immunosuppressants, which transforms into active 6-sulphur-sub-sulphine nucleic acid, inhibits the synthesis of lymphocytes and thus inhibits the growth of lymphocytes.
3. Biological agents
– Belleyu is a single clone antibodies for Blymphocyte irritant (BLyS). It reduces the survival and fragmentation of B cells, thus reducing the generation of its own antibody. Biological agents provide new treatment options for incurable SLEs or patients who cannot withstand the side effects of traditional immunosuppressants.
II. Non-pharmacological treatment
1. Sunscreening
– Ultraviolet exposure is one of the major contributing factors to SLE ‘ s morbidity and increase. Patients should do their utmost to avoid going out during periods of intense sunlight, using physical sunscreen measures such as parasols, wide-banded caps and long-sleeved clothing, while wearing a multi-fold sunscreen.
2. Healthy lifestyles
– The patient should have adequate sleep and a reasonable diet. Nutritional balance should be ensured in diet, and foods rich in nutrients such as vitamins and proteins, such as fresh vegetables, fruits, skinny meat, fish, etc. should be consumed. Appropriate sports also help to increase the body ‘ s resilience, but avoid overwork.
Periodic review
– Due to SLE ‘ s complexity and variability, patients are required to visit the hospital regularly. The review programme includes examinations of blood, urine, liver and kidney function, self-antibody, etc., so that doctors can keep abreast of changes and adjust treatment programmes.
Systematic treatment of erythalamus is a long-term process that requires close cooperation between the patient and the doctor. As medicine continues to develop, new treatments and medicines are emerging and patient prognosis is gradually improving.